Use of β-lactam/β-lactamase inhibitors for extended-spectrum-β-lactamase infections: defining the right patient population

β-Lactam/β-lactamase inhibitors (BLBLIs) were compared to carbapenems in two cohorts of hematological neutropenic patients with extended-spectrum-β-lactamase (ESBL) bloodstream infection (BSI): the empirical therapy cohort (174 patients) and the definitive therapy cohort (251 patients). The 30-day c...

Full description

Autores:

Tamma , Pranita
Villegas, María Virginia

Tipo de recurso:

Article of journal

Fecha de publicación:

2017

Institución:

Universidad El Bosque

Repositorio:

Repositorio U. El Bosque

Idioma:

eng

OAI Identifier:

oai:repositorio.unbosque.edu.co:20.500.12495/3503

Acceso en línea:

http://hdl.handle.net/20.500.12495/3503
https://doi.org/10.1128/AAC.01094-17
https://repositorio.unbosque.edu.co

Palabra clave:

Beta-Lactamas
Inhibidores de beta-Lactamasas
Carbapenémicos
ESBLs
Bloodstream infection
Neutropenia

Rights

openAccess

License

Acceso abierto